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LETTERS
Powassan Virus  
Encephalitis,  
Minnesota, USA
To the Editor: Birge and Son-
nesyn report the first death of a Min-
nesota resident caused by Powassan 
virus (POWV) (1). However, they 
provide an inaccurate description of 
several critical diagnostic and surveil-
lance issues concerning POWV.
The 17 POWV infections detect-
ed in Minnesota residents from 2008 
through 2011 (6 cases were identi-
fied through 2010, not 8 as reported 
by Birge and Sonnesyn) (Minnesota 
Department of Health [MDH], unpub. 
data) were found through enhanced 
surveillance. Health alerts to Min-
nesota medical providers described 
POWV as a possible etiologic agent 
for viral meningitis and encephalitis. 
Providers consulted with MDH on 
suspected cases and submitted serum 
and cerebrospinal fluid specimens to 
MDH. MDH conducted serologic test-
ing for endemic arboviruses (includ-
ing POWV) and reverse transcription 
PCR (RT-PCR) for flaviviruses and 
POWV. MDH would not have de-
tected any POWV infections without 
enhanced surveillance. Limited field 
studies also identified POWV-infected 
ticks in 4 Minnesota counties (not 2 as 
reported [1]) (MDH, unpub. data).
Commercial laboratories do not 
provide testing for POWV, and only 
a few state health department labo-
ratories and the Centers for Disease 
Control and Prevention offer testing. 
Serologic testing (enzyme immuno-
assay with plaque-reduction neutral-
ization testing confirmation) is pre-
ferred (2) because POWV RT-PCRs 
are not validated, and the short vire-
mic periods of flaviviruses limit their 
usefulness (3).
Few POWV infections are identi-
fied by lineage (prototype vs. deer tick 
virus); Minnesota’s first case in 2008 
was identified as a deer tick virus in-
fection, but the lineage was unknown 
for the other 16 cases. However, many 
case-patients had likely exposure to 
Ixodes scapularis ticks (blacklegged 
ticks), the tick species associated with 
deer tick virus transmission, and virus-
es from all POWV-positive tick pools 
were confirmed as deer tick virus by 
sequencing. The distribution of the 2 
lineages in North America is poorly 
understood, and most cases likely go 
undetected without specific POWV 
surveillance efforts.






  1.  Birge J, Sonnesyn S. Powassan virus en-
cephalitis, Minnesota, USA. Emerg In-
fect Dis. 2012;18:1669–71. http://dx.doi.
org/10.3201/eid1810.120621
  2.  Hinten SR, Beckett GA, Gensheimer 
KF, Pritchard E, Courtney TM, Sears 
SD, et al. Increased recognition of Pow-
assan encephalitis in the United States, 
1999–2005. Vector Borne Zoonotic Dis. 
2008;8:733–40.
  3.  Lanciotti RS. Molecular amplification as-
says for the detection of flaviviruses. Adv 
Virus Res. 2003;61:67–99. http://dx.doi.
org/10.1016/S0065-3527(03)61002-X
Address for correspondence: David F. Neitzel, 
Minnesota Department of Health, Infectious 
Disease Epidemiology, 625 Robert St N, PO 
Box 64975, St. Paul, MN 55164, USA; email: 
david.neitzel@state.mn.us
Hepatitis E  
Virus and  
Porcine-derived 
Heparin
To the Editor: Cases of spo-
radic, locally acquired hepatitis E 
have been increasingly identified in 
industrialized countries over the last 
few years (1). In this setting, hepatitis 
E is thought to be a zoonotic infec-
tion, with pigs as the primary host. 
Consumption of uncooked or lightly 
cooked pork meat products is thought 
to be a key route of infection, but oth-
er routes of transmission have been 
documented (2). For example, there 
have been several iatrogenic cases 
after transfusion of hepatitis E virus 
(HEV)–contaminated blood products 
(3) and transplantation of an HEV-
infected donor liver (4). However, in 
most cases the source and route of in-
fection are uncertain.
In May 2011, a 42-year-old 
woman sought care at the Royal 
Cornwall Hospital in Truro, United 
Kingdom, for a 1-week history of 
malaise, diarrhea, nausea, and vom-
iting. Physical examination results 
were normal. Her liver function test 
results, however, indicated hepatitis: 
alanine aminotransferase 2,785 IU/L 
(reference range 10–36 IU/L), alka-
line phosphatase 319 IU/L (reference 
range 30–130 IU/L), and bilirubin 30 
µmol/L (reference range <21 µmol/L). 
HEV IgM and IgG serologic test re-
sults for the patient were positive, 
and HEV genotype 3 was identified 
in her blood by reverse transcription 
PCR and sequencing. Other causes 
of viral hepatitis and hepatocellular 
jaundice, including hepatitis viruses 
A, B, and C; Epstein-Barr virus; and 
autoimmune hepatitis, were excluded 
by testing. As with most immunocom-
petent persons with HEV, the patient 
made an uneventful clinical recovery 
after 12 weeks, and her liver func-
tion tests returned to normal after 
8 weeks.
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